Diffuse astrocytic and oligodendrogial tumors Flashcards

1
Q

Diffuse astrocytoma, IDH mutant

A
ATRX, loss
T2/FLAIR hyperintense, expansile, involves both cortex and white matter
Vasogenic edema is absent
Non enhancing ?
Majority of diffuse astrocytomas
CDKN2A/B retained -> WHO grade 2 or 3
CDKN2A/B homozygotely deleted or necrosis/MVP -> WHO grade 4
FLAIR-mismatch, age <40, size >6cm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Oligodendroglioma, IDH mutant and 1p/19q codeleted

A

ATRX retained
T1 hypo
T2/FLAIR hyperintense
expansile, indistinct margins, hetergenenous, involves both cortex and white matter, frontal lobe
Vasogenic edema is absent
SWI - blooming (calcifications)
CE - variable 50% and not prognostic
DWI - normal
Moderatly elevated rCBV
PET - FDG - if as gray matter or MET/FET anaplastic
MRS - moderate Cho, decreased Naa, no lactate (anaplastic have lactate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pilocytic astrocytoma

A

WHO grade 1
BRAF-fusion - MAPK-pathway - good prognosis
Most common pediatric tumor and most common pediatric cerebellar tumor
NF-1 (PA, optic pathway glioma)
expansive - cerbellum (60%)/cerebral hemispheres
- well circumsribed with solid part (T2/FLAIR hyper, T1 hypo, intense CE) and cystic part (+/-wall enhancement, fluid content (follows CSF)). No edema
infiltrative - elongating and widening of the optic nerve, T2 hyper, moderate CE
MRS - high Cho, latate doublets
DWI - high ADC
PWI - low rCBV, first-pass curve
new - high grade astrocytoma with piloid features (IDH wt, CDKN2A/B, ATRX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pilomyxoid astrocytoma

A
WHO grade 2
BRAF V600E (substitution)
Young children 
Hypothalamus/optic chiasm (60%)
T2 hyper
DWI - high ADC
SWI - hemorrhage 20%
intese heterogenous CE
CSF dissimination is common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pleomorphic xhantoastrocytoma

A
WHO grade 2-3
BRAF V600E (substitution)
Young adults
cortical temporal lobe
seizures
dural attachement/tail
well circumscribed
Solid component (iso on CT, T1 and T2, FLAIR hyper)
CE homo/heterogeneous 
marked vasogenic edema
50% cysts
associated with cortical dysplasia, ganglioglioma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ganglioglioma

A
WHO grade 1
BRAF V600E (substitution)
most common glionerual neoplasm, 1% of intracranial tumors
glial component affects the biological behavior
temporal, frontal lobe
shrply/poorly margins, solid/cystic/ cyst with a nodule
CT - low density
no edema
Ca 35%
erosion of inner table of scull
T2 hyper
T1 variable signal
CE - variable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hemangioblastoma

A

flow voids
peritumoral edema
elevated rCBV (8-10)
vHL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ependymoma

A

Anywhere in the CNS, posterior fossa
1-6y (supratentorial 18-24y)
3-5% of intracranial neoplasms
plastic - extends through foramina
Cysts
Calcification
Hemorrhage
DWI - mildly restricted
can seed
RELA - supratentorial, older children, poor prognosis
YAP1 - supratentorial, younger children, good prognosis
Posterior fossa A - young, lateral recess, poor prognosis
Posterior fossa B - older children, midline, good prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Medulloblastoma

A

DWI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of temporal lobe epilepsy

A
Mesial temporal sclerosis
Ganglioglioma -40%
DNET -20%
Diffuse low grade astrocytoma -20%
Other -20% (pilocytic astrocytoma, pleomorphic xantoastrocytoma, oligodendroglioma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neurofibroma

A
WHO grad 1
NF1
fusiform
no cyst/hemorrhage
T1 hypo
T2 hyper +/- hypo central (target sign)
CE - heterogenous mild or no enhancement 
3 types: localised intraneural (90%), diffuse cutaneous, plexiform
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Schwannoma

A
WHO grade 1
Antoni A/B growth pattern
Local mass effect/nerve dysfunction
CN (not olfactory (filia) or optic), vestibulocochlear is most common
Round
Cysts/hemorrhage/fatty degeneration
Displace nerves
NF2/schwannomatosis
T1 iso/hypo
T2 heterogenous
SWI - hemosidering in larger tumors
CE - strong
Subtraction imaging for assessment of growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Meningioma of pontine angle

A
Dural base
Dural tail
Isointense with gray matter
Perpendicular to nerves courses
Homogeneous enhancement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Multinodular and vacuolating tumor

A
parietal and temporal
seizures
juxtacortical cluster of tiny well-defined nodules
T2/FLAIR hyper (ddx PVS)
no edema
no enhancement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dysembryoblastic neuroepitelial tumor

A
Supratentorial
WHO grade 1
temporal and frontal
seizures
associated with cortical dysplasia
wedge shape, multycystic "bubbly"
T2 hyper
FLAIR - bright rim sign
enhancement 33%
no edema
remoddeling of adjecent bone
ddx: diffuse astrocytoma, oligodendroglioma, pleomorphic xanthoastrocytoma, ganglioglioma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gangliocytoma

A

Supratentorial
very rare
exclusive ganglion cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Desmoplastic infantile ganglioglioma

A
Supratentorial
Very large tumor in 1st year
frontal, parietal
both cystic and solid
poor prognosis
ddx: teratomas, choroid plexus papilloma, AT/RT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Papillary glioneural tumor

A

Supratentorial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Central neurocytoma

A
Intraventricular (may be extraventricular)
WHO grade 2
Young and middle age adults
Third and lateral ventricles, attached to the septum pellucidum
Ca 50-70%
CT - mixed density
T1 iso
T2 bubbly
FLAIR heterogeneous
hydrocephalus is common
CE - moderate/heterogenenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Rosette-forming glioneural tumor of the 4th ventricle

A

Infratentorial intraventricular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos)

A
Infratentorial parenchymal
Cerebellum or vermis
WHO grade 1
T2 striate pattern (hyper/iso)
Cowdens syndrom (multiple hamartoma syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cerebellar liponeurocytoma

A

Infratentorial parenchymal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Paraganglioma

A

filum terminale
WHO grade 1
very rare
increased vascularity - feeding vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Myxopapillary ependymoma

A
WHO grade 2 (2021)
children and young adults
glial cell of filum terminale
83% of primary tumors in that area
multiple in 43%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Embryonal tumors with multilayered rosettes
``` C19MC 95% - amplification (cluster of fetal neural tubes) LIN28A - if present poor prognosis under 2 years poor outcome Cerebral hemispheres 76%, cerebellum, brain stem, pre-sacral space, optic nerve Large heterogeneous (haemorrhage/Ca/cysts/necrosis) may be exophytic No edema DWI - restricted CE - mild/no CT - hyperdense ```
26
Atypical teratoid rhabdoid tumor
WHO grade 4 2% of CNS tumors in children 10% under 1 y, can be congenital INI1 gene - loss of tumor suppression BRG1 gene somatic or germ line mutation (rhabdoid tumor predisposition syndrome, kidney, lugns, skin, liver) if no mutation (CNS embryonal tumor with rhabdoid features) posterior fossa 52%, supratentoral 39%, pineal, spinal, multifocal intra/extra axial marginal cyst, calcification, haemorrhages DWI - restricted PWI - increased MRS - high Cho, lipid peak, no creatin/Naa rapid growth CE - may not enhance DWI to look for metastasis
27
Medulloblastoma
CT hyperdens Calcification, haemorrhage, cysts, necrosis T1 T2 Ce - no/homogeneous/inhomogeneous DWI - restricted SHH 25% hemispheric (A), mildine-intraventricular (B), midline-extraventricular/vermis (C) WHT 11% midline - intraventricular (A), midline-cisternal (B), off-midline-intraforaminal (C), off-midline-intracisterna (D) Group 3 + 4 65%, midline-intraventricular MYC - poor prognosis
28
Desmoplastic medulloblastoma
younger than 3y
29
Keratocytic odontogenic
primary odontogenic, most common, uni-or multicystic, PTCH, mandible, tooth displacement and tooth resorption, tendency of recurrence, GorlinGoltz syndrome (multiple), DWI
30
Ameloblastoma
primary odontogenic, second most common, partially solid/multicystic, BRAFV600, unerupted 3rt molar, locally invasive mandible
31
Odontogenic myxoma
primary odontogenic, multilocular, expansile, well defined borders, honeycomb
32
Odontoma
primary odontogenic, malformation (hamartoma) compound (tooth) or complex (doesn’t look like tooth)
33
Osteoma
osteogenic, cortical, fronto-ethmoid, jaws (angle, coronoid process, condyle), Gardners syndrome (multiple)50-60y
34
Osteoblastoma
osteogenic, >2cm, cortical and cancellous, fronto-ethmoid, orbit or jaw, 20y
35
Chondroblastoma
chondrogenic, maxilla, mandible or skull base, lytic with areas of calcification
36
Osteochondroma
pedunculated exophytic bony projection of cortical and cancellous bone, condyle or coronoid process
37
Giant cell tumor
osteolytic +/-matrix calcification, hemorrhage, mandible, maxilla, ethmoid, sphenoid, temporal bone
38
Fibrous dysplasia
Fibro-osseous lesions (+ ossifying fibroma, osseous dysplasia) expansile proliferation of trabecular bone + fibrous tissue, maxilla, mandible, zygoma, spheno-ethmoid, externa cortical bone protrusions, notion of growth by Gd
39
Ossyfying fibroma
Fibro-osseous lesion (+ fibrous dysplasia osseous dysplasia) | fibrocellular and mineralized, mandible, maxilla, paranasal sinus. Demarcation and encapsulation
40
Osseous dysplasia
Fibre-Osseous lesions (+ fibrous dysplasia ossifying fibroma) replacement of bone by fibrous tissue and metaplastic bone, periodontal ligament
41
Chondrosarcoma
chondrogenic, osteolyticm cortical destruction, calc soft tissue, alveolar maxilla, maxillary sinus, spetum zygomatic bone
42
Osteosarcoma
osteogenic, lobulated, lytic,-mixed or sclerotic, alveolar maxilla, body mandible
43
Pleomorphic adenoma
Benign
44
Adenocystic carcinoma
Malignant
45
Mucoepidermoid carcinoma
Malignant
46
Adenocarcinoma
Malignant
47
Dentigerous cyst (follicular cyst)
Pseudotumor, encloses crown of unerupted tooth, attaches to the cement-enamel junction
48
Primoderal cyst
Pseudotumor, replace tooth
49
Residual cyst
Pseudotumor, following tooth extraction
50
Inflammatory cyst (radicular cyst)
Pseudotumor, result of apical periodontitis, maxilla and mandible
51
Naso-palatine cyst
Non-odontogenic (fissural) cyst, developmental, foramen incisivum, sometimes unilateral
52
Naso-alveolar cyst
Non-odontogenic (fissural) cyst, developmental, submucosal anterior to premaxilla, posterior to nasal ala
53
Simple bone cyst
Non-odontogenic pseudocysts, corticallated scalloped unilocular cyst in mandible, no root resorption, nonexpansile
54
Stafne cyst
Non-odontogenic pseudocysts, developmental defect anterior to angle of mandible, part of submandibular gland
55
Perineural spread
most common in cutaneous and mucosal malignances (BCC, SCC), salivary gland malignancies (especially ACC), nasopharyngeal carcinoma, desmoplastic melanoma, lymphoma, leukemia and myeloma
56
Diffuse astrocytoma, IDH wt
``` WHO grade 4 Older, multifocal brainstem No cystic changes DWI - restricted CE - variable PWI - difficult MRS - 2HG IDH might be lowered ```
57
Diffuse midline glioma
``` H3.1/3, K27M, H3 27 wt WHO grade 4 5-11y poor prognosis midline - thalamus, pons, spinal cord ```
58
Gliomatosis cerebri
Growth pattern, | 3 lobes
59
T2-FLAIR mismatch
``` Indicative of No CE IDH-m in astrocytomas (not oligodendrogliomas) T2 hyperintense FLAIR hypo with hyperintense rim ddx bright rim sign in DNET ```
60
MR-IDH status
T2-FLAIR mismatch - IDHm DWI - restricted - IDHwt MRS - 2HG - IDHm
61
Glioblastoma
most common malignant brain tumor Intraaxial, gray+white matter, more frequent supratentorial CE - solid/necrotic/cystic, non spherical PWI - rCBV >1.75, increased permeability, high CBF SWI - intratumor suseptibility (necrosis/hemorrhage + vessels) DWI - variable, often restricted diffusion non-enhancing tumor - WM, may involve GM, MRS - Cho peak, APT, DWI and PWI may be abnormal
62
Abscess
DWI - restricted in necrosis | PWI - DSC no angiogenisis
63
Acute demyelination lesion
``` Low mass effect incomplete ring look for other lesions DWI - varaible PWI - normal rCBV in enhancing part ```
64
Subacute infarct
high T1 in cortex gyriform enhancement PWI - normal rCBV in enhancing part SWI - low cortical signal
65
PWI - rCBV
High - glioblastoma, high-grade glioma, metastasis, medulloblastoma, capillary telangiectasia Low - lymphoma, desmoplastic medulloblastomas, pilocytic astrocytoma, vascular, traumatic contusion, inflammation, abscess
66
Lymphoma
Solid enhancement (rarely necrotic/HIV) DWI - restricted PWI - rCBV normal or low, high K2 SWI - normal
67
Metastasis
Solid or necrotic, spherical MRS - lipids PWI - high rCBV Edema - centered by the lesion, marked T2/FLAIR, no mass effect, facilitated DWI, low PWI, normal MRS
68
Subependymoma
``` 0.5% of intracranial neoplasms fourth ventricle, lateral ventricle 50-60y WHO grade 1 well circumscribed, cysts are common, can calcification/haemorrhage CE - no or minimal No CSF seeding ```
69
Choroid plexus tumors
``` <5y (2-4% of paediatric brain tumors) trigone of lateral ventricle Papilloma - WHO grade 1 Atypical papilloma - WHO grade 2 Carcinoma - WHO grade 3 Cauliflowerlike lobulated mass, can haemorrhage/calcifications/necrosis Hydrocephalus is common CSF seeding CE - present ```
70
Subependymal giant cell tumor
``` Foramen of Monroe, well marginated, lobulated, heterogenenous (calcifications) 15% of patients with TS WHO grade 1 No CSF seeding CE - strong Hydrocephalus ```
71
Intraventricular meningioma
``` Atrium of lateral ventricle 30-60y Slow growing (large size) Can cyst/calcification CT iso/hyper Local CSF-obstruction ```
72
Central neurocytoma
``` 0.5% on intracranial neoplasm Septum pellucidum or lateral wall of lateral ventricle Well circumscribed lobulated mass, bubbly, can haemorrhage/calcifications CT hyper CE - variable 29y Hydrocephalus WHO grade 2 ``` Synaptophysin stain
73
Rosette-forming Glioneural tumor
``` Rare WHO grade 1 31.5y Hydrocephalus Fourth ventricle Fairly well circumscribed, heterogeneous solid and cystic ```
74
CSF drop metastasis
``` Ependymoma Choroid plexus tumors Germinoma Medulloblastoma Pineoblastoma Enedymal invasion - GBM ```
75
Craniopharyngeoma
craniopharyngeal duct remnant - floor of third - pituitary 10-14y/40-60y Cystic/solid with variable signal in cysts, can calcification T1 hyper CE - solid nodules
76
Germinoma
``` child/young adults Pineal and/or hypothalamus T2 hyper CE - homogeneous CT - slight hyper ```
77
Meningioma
15-20% of intracranial tumor in adult Arachnoid cap cells/meningocytes 50% falx, parasagittal, lateral convexity 40% basal, subfrontal, olfactory groove, sphenoid wing and suprasellar Dural based, CSF cleft, widening of subarachnoid spaces, intervening vessels, dural tail, hyperostosis (reactive hypervascularity)/erosion of calvarium CT - hyperdense T1 iso/hypo T2 iso/hyper CE - homogeneous, in bone - intraosseous Edema 60% Hemorrhage is rare WHO grade 1, 2 (atypical, papillary, rhabdoid) and 3 (anaplastic - may infiltrate of brain) Look for vascular encasement, venous infiltration, hypervascularity
78
Epidermoid
CSF like on CT, T1 and T2 | DWI - restricted
79
Hemangiopericytoma
``` Younger than meningioma Agressive tumor CE - vivid T2 - flow voids Narrow base of dural attachment Edema in adjacent brain ```
80
Primary CNS lymphoma
B-cell 90% 45-70y immunodeficiency Parenchymal mass close to surface T2 hypo DWI - restricted (EBV hyperintense rim) Solitary or multiple (50%) CE - homogeneous, ring (HIV, EBV - 90%), perivascular, ascent Hemorrhage (HIV, EBV - 70%) steroid treatment - tumor regression, decrease CE and rCBV and increase ADC Differentiate from GMB: ADC, rCBV and FDG-PET Cave - post treatment T1 hyper Treatment - MATRIx - response DWI, PWI and FDG-PET
81
Secondary CNS lymphoma
10-15% of NHL More frequent in relapsing disease 2/3 leptomeningeal, 1/3 parenchymal CE - leptomeningeal, dural, subependymal, CN
82
Leukaemia
ALL - children - CNS profylax is standard AML - adults Leptomeningeal and CN infiltration Granulocytic sarcomas (chloromas) - intraparenchymal, CE - strong, DWI - restrict, can be hemorrhagic, dural based, calvarium, orbit, sinuses Cerebral hemorrhage Bone marrow infiltration
83
Neurofibromatosis Type 1
1/3000 Cafe-au-lait, neurofibroma/plexiform neurofibroma, axillary/ingunial freckling, optic nerve glioma (PA, 4-5y), Lisch noduli, sphenoid dysplasia, relative with NF1 Gliomas in NF1 - brainstem (diffuse/focal) medullary, pontine, midbrain UBO - appear at 3-4y and disappears 10-12y - no mass effect or CE, MRS - preserved Cho/Naa ratio Gliomas - slow progression, might regress Moyamoya, arteria ectasia and aneurysm
84
Plexiform neurofibromas
WHO grade 1 Tortuous, aggressive, infiltrating the nerves T1 iso to muscle T2 hyper, inhomogeneous CE - inhomogeneous 10% malignant peripheral nerve sheath tumor
85
Spinal neurofibroma
Scoliosis NF1 Dumbell
86
Neuroblastoma
Peripheral nerves 7-8% of paediatric tumors <5y
87
Neurofibromatosis Type 2
1/25000 Merling MISME (multiple inherited schwannomas, meningiomas and ependymomas) Bilateral schwannomas or relative with NF2 Meningiomangiomatosis - rare hamartomatous lesion
88
Tuberous Sclerosis Complex
1/6000 Hamartin, Tuberin Cortical tuper (=focal cortical dysplasia), often calcification WM abnormalities - transmantal sign Subependymal nodules - lateral wall of lateral ventricle, candle guttering, calcification common, may enhancement SEGA - foramen of monroe, 2-26%, rapamycin
89
Sturge-Weber
Facial capillary vascular malformation - trigeminal territory Leptomeningeal angiomatosis - multiple thin vessels in leptomeninges - enhancement of cortical surface - atrophy and calcifications Angiomatosis of the choroid of ipsilateral eye Hypertrophy of choroid plexus No tumor
90
Von Hippel-Lindau
Systemic | Hemangioblastoma - highly vascularised nodule that abuts the pial surface cystic component (reactive)
91
Hemangioblastoma
``` highly vascularised nodule that abuts the pial surface cystic component (reactive) Cherry on angiography T1 hypo T2 hyper CE - strong, non enhancing cyst wall PWI - high rCBV ```
92
Neurocutaneous syndroms
``` NF1 - PA, neurofibroma NF2 - schwannoma, meningioma, ependymoma Tuberous sclerosis - subependymal giant cell astrocytoma Sturge-Webe syndrome - none Von Hippel Lindau - hemangioblastoma ```
93
Spinal Ependymoma
``` 40-50y (NF2 - children) T2 hyper T1 hypo 85% central CE - vivid Well defined borders, neoplastic cysts (tumoral/non tumoral) 30% cap sign ```
94
Myxopapillary ependymoma
``` Conus and cauda WHO grade 1 multilobulated, cystic, haemorrhage CE - always Scalloping of vertebral bodies CFS spread ```
95
Spinal Astrocytoma
``` 30-40y (most common intramedullary tumor in children, PA) Fusiform expansion of cord T1 iso/hypo T2 hyper inhomogeneous, illdefined margins CE - heterogeneous, 60-70% May have haemorrhage 30% satellits cysts ```
96
Spinal Hemangioblastoma
Benign, rich vascularised (flow void) 2-6% of spinal tumors If multiple - vHL small nodule with extensive edema or extensive cyst
97
Intramedullary metastasis
Edema T1 iso T2 hyper CE - nodular
98
Intramedullary epidermoid
"cholesteatoma" 1% slow growing, lumbosacral, dermal sinus in children congenital or acquired
99
Melanocytoma
``` Leptomeningeal melanocytes, intradural extramedullary WHO grade 1 T1 hyper T2 hypo CE - uniform ```
100
Spinal Meningioma
Intradural, extramedullary 80% thoracic (posterolateral), 15% cervical (anterior) 50-60y T2 hyper T1 iso/hypo CE - vivid, homogeneous well circumscribed, delineated from the spinal cord
101
Spinal nerve sheath tumor
60% intradural extramedullary, 25% extradural, 15% both cervical or lumbar schwannoma 65%, neurofibroma, ganglioneuroma (rare) 40y T1 iso T2 hyper, sometimes target sign CE - variable
102
Spinal neurofibromas
Neurofibromin NF1 T2 target sign CE - central or heterogeneous
103
Spinal schwannomas
``` = neurinoma Merlin NF2 hemorrhage, cyst CE - diffuse ```
104
Paraganglioma
``` Adrenal (pheocromocytoma), carotid body and gloms jugular Conus, cauda and filum 30-60y WHO grade 1 SDHD - mutation T1 iso T2 hyper inhomogeneous, haemorrhage, intratumoral and adjacent vessels with flow void and strong enhancement ```
105
Spinal eosinophilic granuloma
0-10y, vertebral body
106
Spinal osteoid osteoma
10-20y, posterior elements
107
Spinal aneurysmatic bone cyst
10-20y, involvement of adjacent levels, posterior elements
108
Spinal giant cell tumor
20-50y, involvement of adjacent levels, vertebral body, posterior elements
109
Plasmacytoma
40-60y, involvement of adjacent levels, vertebral body | oval with sharp margins in scull base, clivus and petroclival
110
Chordoma
40-60y, involvement of adjacent levels, vertebral body
111
Spinal hemangioma
40-60y, multiple lesions, vertebral body
112
Multiple myeloma
50-70y, multiple lesions, vertebral body
113
Spinal metastasis
50-70y, multiple lesions, vertebral body
114
Spinal lymphoma
Multiple lesions, involvement of adjacent levels, vertebral body
115
Spinal sarcoma
Involvement of adjacent levels, posterior elements
116
Spinal metastasis
Arterial seeding, retrograde venous or direct extension SPECT - osteoblastic WB-MRI and/or PET
117
Malignant spinal bone tumors
Lytic without marginal sclerosis surrounding bone edema invasion of neighbouring structures Diagnostic clues: multiplicity, age, imaging characteristics and location
118
Normal red marrow
<6 moths - low/homogeneous, no enhancemnet 6 months - 45y - intermediate/homogeneous, very limited enhancemnet >45 y - intermediate/heterogeneous, no enhancement (high SI - more fat, low SI - more cells)
119
Bone marrow metastasis
Decreased signal =
120
Spinal hemangioma
``` T1 high to low T2 high Fat-sat-fluid-sensitive - high CE - yes CT - polka dot ```
121
Benign notochord cell tumor
``` T1 low T2 high Fat-sat-fluid-sensitive - intermediate CE - no Small, sclerotic, hydrated, non-enhancing ```
122
Focal red marrow hyperplasia
``` T1 low T2 low Fat-sat-fluid-sensitive - intermediate CE - subtle signal as cellular red marrow CT - normal/subtle sclerosis ```
123
Ethmoid mucocele
Completely opacified and expanded sinus (cell)
124
Allergic fungal sinusitis
Expanded sinuses with hyper dense stuff Images /symptoms mismatch Teenagers
125
Encephalocele
``` Ideopathic intracranial hypertension Lateral sphenoid (NOT sternbergs canal) ```
126
Persistant craniopharyngeal canal
.
127
Inferior median clival canal
= canalis basilaris medianas, fossa naviculars
128
Ecchordosis physaliphora
Remnant of notochord T1 hypo T2 hyper CE - variable
129
Chordoma
From clivus, osteolytic, hypodense, may be off midline T2 very high DWI - very high ADC CE - variable (minimal)
130
Chondrosarcoma
Petroclival junction (cartilage) whirls of calcs 50% CE - stippled DWI - very high ADC
131
Hemangioma of cavernous sinus
T2 very high DWI - very high ADC CE - avidly enhancement
132
Glomus jugulare
Enhancing mass with flow voids | Infiltrative osteolysis
133
Jugular schwannoma
Smooth bone remodelling DWI - high ADC T2 hyper CE - avid
134
Endolymphatic sac tumor
``` T1 hyper T2 hyper Infiltrative, osteolytic Centered at endolymphatic duct CE - heterogeneous ```
135
Cholesterol granuloma
Smooth, sharp Petrous apex expansion T1 hyper T2 hyper, hemosiderin rim
136
Arachnoid granulations
Along sinuses Lobulated bone remodeling Not always T2 hyper
137
Pituitary adenoma
CE - less and more slow than normal pituitary | Ddx - meningioma ehnacenes more than pituitary, reduces artery
138
Cavernous angioma
CE - centripetal
139
Rathke cleft cyst
mucoid 25% | intracystic nodules
140
Head and neck lymphoma
Type 1 - nodal Type 2 - extranodal (waldeyers ring/outside waldeyers ring) Type 3 - combined 1+2 Type 4 - multifocal extranodal nodes 2-10cm CE - variable (less than reactive) necrosis calcifications after treatment Reactive - multiple, well defined, mild enhancement, ADC >1 (metastasis larger, necrosis, ADC>0.7) HL - 90% nodal, T2 hyper NHL - multiple, bilateral solid, CE - moderate (retropharyngeal, occipital, parotid, posterior triangle, submandibular), T2 iso 5% of salivary tumors, parotid 70% Ocular adnexa >60y most common orbital malignancy
141
Mucocele
thin rim of the bone | MR signal, CT density variable
142
Inflammatory pseudotumor
rare, benign | nonspecific imaging - rule out other lesions
143
Dacroadenitis
OID gland, orbital and palpebral lobes, almond shape
144
Myositis
OID unilateral thickening of one or two EOM superior oblique surrounding fat, tenons and myotendinous junction ddx: thyroid (I'm slow), cellulitis (CT), CCF (enlarged vein), metastasis (focal mass), lymphoma (focal mass, ADC)
145
Optic perineuritis
``` OID optic nerve sheath pain CE - enhancement of sheath and adjacent fat ddx: meningioma, optic neuritis ```
146
Optic meningioma
Tram-track no pain CT - calcifications
147
Optic neuritis
``` spare soft tissue different vision imparement swollen nerve T2 hyper CE - contrast enhancement ```
148
Periscleraitis
sclera, uvea and tenons capsule | thickening along the outer rim of the eye, periscleral fluid collection